... Purpose: The aim of this in vitro study was to estimate surface characteristic after peptide coating and investigate biological response of human mesenchymal stem cell to anodized titani[r] ...
... engineering, Humanmesenchymalstemcell, Osteogenic capacity 7) 최근에 와서 인공 장기의 개발 및 조직 재생을 위 한 조직 공학적 기법에의 적용에 널리 연구되고 있 는 줄기세포는 배아 줄기세포와 성인 줄기세포로 나 뉘며 법적, 윤리적 문제로 인한 배아 줄기세포 연구 의 어려움으로 뇌조직, ...
... that human hMSCs can be induced to differentiate into neuron-like cells (Mareschi et ...hMSCs, cell therapy with hMSCs has an advantage in clinical ...embryonic stemcell therapy, there is no ...
... 로 알려져 있다. 이러한 프로티오믹스 프로필링 연구는 향후 뇌졸중 치료에 있어 서 MSC 의 작용기전을 연구하고 해석하는데 도움이 될 것으로 사료된다. 실험 III: MSC는 뇌졸중 치료에서 손상된 뇌 기능을 회복하는데 유익하다고 보고 되어있다. 이런 MSC의 치료효과는 대사체의 변화에서도 반영될 것으로 추 측된다. 본 실험에서는 허혈성 뇌졸중 쥐에 human MSCs ...
... 행동평가검사의 결과에서 사람의 중간엽줄기세포 또는 신경세포로 분화 유도된 사람의 중간엽줄기세포를 이식한 group2와 group3이 대조군인 group1보다 신경기 능이 통계적으로 의미 있게 호전되었으며,신경세포로 분화 유도된 사람의 중간엽 줄기세포를 이식한 group3이 가장 효과적인 신경기능 회복을 보였다.. 신경세포로 분화 유[r] ...
... DISCUSSION Because NO promotes various EC functions (32), inhibition of NO bioactivity usually reduces angiogenesis, as evidenced by the anti-NO effect of oxidized LDL inhibiting capillary sprouting from segments of ...
... cultured humanmesenchymalstem cells on all 8 ...the stemcell ’attachment with SEM, and on 3rd, 7th, and 14th days, we checked the cell proliferation and differentiation by ...
... Humanmesenchymalstemcell (hMSCs) isolated from human adult bone marrow have self-renewal capacity and can differentiate into multiple cell types in vitro and in vivo ...
... treating human diseases, systematic infusion of BMSCs has been used to treat children with severe osteogenesis ...8 cell/kg unmanipulated nucleated cells from ...
... these cell types are now vital elements in tissue engineering of therapeutic bone replacements, it is important to test the osteoinductive responses of cell types with strong clinical ...
... of human origin and whether they had hepatocyte phenotypes because the present study was not designed to confirm the ability of the infused MSCs to differentiate into other cell types after ...adult ...
... in human MSCs. Then, we investigated cell survival or death related ...of human ADC increases formazan production and reduces caspase 3 activation and the numbers of FITC, hoechst, or propidium ...
... on mesenchymalstemcell (MSC) differentiation, which may affect bone ...Methods: Human MSCs (hMSCs) were committed to differentiate when either adipogenic or osteogenic media was added, ...
... in human genome may be regulated by miRNA 43) , and con- sidering the unparalleled advance in tech- nology as well as the continued global effort to gain complete understanding of miRNA, its use and applicability ...
... optimal cell type for infusion, the optimal therapeutic timing, the most effective number of cells, the best route of administration and the optimal period or number of ...resident stem cells ...of ...
... DISCUSSION T2DM has become one of the greatest challenges to human health nowadays. More and more people are suffering from T2DM, and many drugs are being used to treat T2DM, which is not easy to treat, because of ...
... The utilization of the cord blood stem cells starts with the treatment of pediatric hematological malignancies. For example, ‘Eurocord Registry’ has reported the results of 65 allogeneic UCB-stem ...
... and CD34- cells were isolated and cultured under the endothelial cell growth medium and mesenchymal stem cell growth medium respectively. The present study showed that ESC-like cells cou[r] ...